ArticleCancer research2016

HSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors.

Anna Budina-Kolomets et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.